Vaccine trial results in 88% survival rate after 3 years Aitrend
Study author, William Gillanders – credit, SWNS Breast cancer patients have found new hope after a new vaccine showed “promise” in treating an aggressive form of the disease. The findings come from a clinical trial involving U.S. patients with triple-negative breast cancer who received an experimental drug designed to prevent tumors from recurring. The trial, … Read more